The Duality of Human Oncoproteins: Drivers of Cancer and Congenital Disorders

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2020 Apr 29

PMID 32341551

Citations 30

Authors

Pau Castel

Katherine A Rauen

Frank McCormick

Affiliations

Soon will be listed here.

Abstract

Human oncoproteins promote transformation of cells into tumours by dysregulating the signalling pathways that are involved in cell growth, proliferation and death. Although oncoproteins were discovered many years ago and have been widely studied in the context of cancer, the recent use of high-throughput sequencing techniques has led to the identification of cancer-associated mutations in other conditions, including many congenital disorders. These syndromes offer an opportunity to study oncoprotein signalling and its biology in the absence of additional driver or passenger mutations, as a result of their monogenic nature. Moreover, their expression in multiple tissue lineages provides insight into the biology of the proto-oncoprotein at the physiological level, in both transformed and unaffected tissues. Given the recent paradigm shift in regard to how oncoproteins promote transformation, we review the fundamentals of genetics, signalling and pathogenesis underlying oncoprotein duality.

Citing Articles

Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.

Finotti A, Gambari R Noncoding RNA. 2025; 11(1.

PMID: 39846681 PMC: 11755495. DOI: 10.3390/ncrna11010003.

Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variants.

Haque B, Cheerie D, Pan A, Curtis M, Nalpathamkalam T, Nguyen J PLoS Genet. 2025; 21(1):e1011540.

PMID: 39761285 PMC: 11737861. DOI: 10.1371/journal.pgen.1011540.

Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy.

Zhang Z, Deng J, Sun W, Wang Z Brain Behav. 2024; 15(1):e70223.

PMID: 39740786 PMC: 11688120. DOI: 10.1002/brb3.70223.

Prediction of viral oncoproteins through the combination of generative adversarial networks and machine learning techniques.

Beltran J, Herrera-Belen L, Yanez A, Jimenez L Sci Rep. 2024; 14(1):27108.

PMID: 39511292 PMC: 11543823. DOI: 10.1038/s41598-024-77028-y.

When, where and which PIK3CA mutations are pathogenic in congenital disorders.

Angulo-Urarte A, Graupera M Nat Cardiovasc Res. 2024; 1(8):700-714.

PMID: 39196083 DOI: 10.1038/s44161-022-00107-8.

References

Wang Y, Velho S, Vakiani E, Peng S, Bass A, Chu G . Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression. Cancer Discov. 2013; 3(3):294-307. PMC: 3595397. DOI: 10.1158/2159-8290.CD-12-0198. View

Shirley M, Tang H, Gallione C, Baugher J, Frelin L, Cohen B . Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013; 368(21):1971-9. PMC: 3749068. DOI: 10.1056/NEJMoa1213507. View

Huang J, Urtatiz O, Van Raamsdonk C . Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice. Cancer Res. 2015; 75(16):3384-97. DOI: 10.1158/0008-5472.CAN-14-3229. View

Charbel C, Fontaine R, Malouf G, Picard A, Kadlub N, El-Murr N . NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol. 2013; 134(4):1067-1074. DOI: 10.1038/jid.2013.429. View

Tavormina P, Shiang R, Thompson L, Zhu Y, Wilkin D, Lachman R . Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet. 1995; 9(3):321-8. DOI: 10.1038/ng0395-321. View

Gripp K, Morse L, Axelrad M, Chatfield K, Chidekel A, Dobyns W . Costello syndrome: Clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019; 179(9):1725-1744. PMC: 8238015. DOI: 10.1002/ajmg.a.61270. View

Schubbert S, Zenker M, Rowe S, Boll S, Klein C, Bollag G . Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006; 38(3):331-6. DOI: 10.1038/ng1748. View

Chompret A, Kannengiesser C, Barrois M, Terrier P, Dahan P, Tursz T . PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology. 2003; 126(1):318-21. DOI: 10.1053/j.gastro.2003.10.079. View

. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014; 159(3):676-90. PMC: 4243044. DOI: 10.1016/j.cell.2014.09.050. View

10.

Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S . Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998; 279(5350):577-80. DOI: 10.1126/science.279.5350.577. View

11.

Rous P . A TRANSMISSIBLE AVIAN NEOPLASM. (SARCOMA OF THE COMMON FOWL.). J Exp Med. 2009; 12(5):696-705. PMC: 2124810. DOI: 10.1084/jem.12.5.696. View

12.

Laurie C, Laurie C, Rice K, Doheny K, Zelnick L, McHugh C . Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet. 2012; 44(6):642-50. PMC: 3366033. DOI: 10.1038/ng.2271. View

13.

Robertson , Tynan , Donoghue . RTK mutations and human syndromes: when good receptors turn bad. Trends Genet. 2000; 16(8):368. DOI: 10.1016/s0168-9525(00)02077-1. View

14.

Oba D, Inoue S, Miyagawa-Tomita S, Nakashima Y, Niihori T, Yamaguchi S . Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis. EBioMedicine. 2017; 27:138-150. PMC: 5828294. DOI: 10.1016/j.ebiom.2017.11.029. View

15.

Cai X, Evrony G, Lehmann H, Elhosary P, Mehta B, Poduri A . Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep. 2014; 8(5):1280-9. PMC: 4272008. DOI: 10.1016/j.celrep.2014.07.043. View

16.

Mosse Y, Laudenslager M, Longo L, Cole K, Wood A, Attiyeh E . Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008; 455(7215):930-5. PMC: 2672043. DOI: 10.1038/nature07261. View

17.

Charles R, Iezza G, Amendola E, Dankort D, McMahon M . Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse. Cancer Res. 2011; 71(11):3863-71. PMC: 3107361. DOI: 10.1158/0008-5472.CAN-10-4463. View

18.

Genovese G, Kahler A, Handsaker R, Lindberg J, Rose S, Bakhoum S . Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-87. PMC: 4290021. DOI: 10.1056/NEJMoa1409405. View

19.

Maher G, Ralph H, Ding Z, Koelling N, Mlcochova H, Giannoulatou E . Selfish mutations dysregulating RAS-MAPK signaling are pervasive in aged human testes. Genome Res. 2018; 28(12):1779-1790. PMC: 6280762. DOI: 10.1101/gr.239186.118. View

20.

Lim Y, Ovejero D, Sugarman J, DeKlotz C, Maruri A, Eichenfield L . Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet. 2013; 23(2):397-407. PMC: 3869357. DOI: 10.1093/hmg/ddt429. View